Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

Cancer - 1 Mar 2018

Harmsen Marline G, Piek Jurgen M J, Bulten Johan, Casey Murray J, Rebbeck Timothy R, Mourits Marian J, Greene Mark H, Slangen Brigitte F M, van Beurden Marc, Massuger Leon F A G, Hoogerbrugge Nicoline, de Hullu Joanne A

Abstract excerpt

BACKGROUND: Risk-reducing salpingo-oophorectomy (RRSO) is recommended for BRCA1/2 mutation carriers because of their increased risk of ovarian carcinoma. Despite RRSO, metachronous peritoneal carcinomatosis occasionally is diagnosed. METHODS: The literature was searched for BRCA1/2 mutation carriers with peritoneal carcinomatosis after risk-reducing surgery. The authors were asked for additional data. Clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Heterozygote

Share to Mutation

Share to Peritoneal Neoplasms

Share to Risk Factors

Share to Salpingo-oophorectomy

Source

Identifiers

PMID: 29315498
DOI: 10.1002/cncr.31211

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.PMID 29315498Read ↗

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers.Semantic proximity Read ↗

Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.Semantic proximity Read ↗

Early diagnosis of peritoneal carcinoma based on a subtle rise in serum CA125 level within the normal range in a BRCA2 mutation carrier with serous tubal intraepithelial carcinoma discovered after risk-reducing salpingo-oophorectomy: A case report and literature review.Semantic proximity Read ↗

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.Semantic proximity Read ↗

Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.Semantic proximity Read ↗

Clinical significance of risk-reducing salpingo-oophorectomy in patients with BRCA1/2 mutation.Semantic proximity Read ↗

Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.Semantic proximity Read ↗

Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.